// App-Quantinova.ai

1816 : The Impact of Different Prophylactic Anticoagulation Doses on the Outcomes of Patients with COVID-19

Researchers

Presenter

  • Rodolfo Jimnez-Soto

Principal Investigators

  • Mercedes Aguilar-Soto

  • Roberta Demichelis

Medical Centers

  • Internal Medicine, Centro Médico ABC, Mexico City, Mexico

  • Rheumatology, Centro Medico ABC, Mexico, Mexico

Locations

  • Mexico

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Venous thrombosis

  • Coronavirus disease

Biomarkers

  • N/A

Drug/Treatment

  • Enoxaparin

  • Enoxaparin sodium

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved